Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-04-25
1992-11-24
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514333, 514336, 514337, 514343, 514357, 514374, 514378, 514381, 514382, 514397, 514399, 514400, 514414, 514415, 514470, 514511, 514512, 514521, 514528, 514530, 514531, 514533, 514534, 514538, 514539, 514542, 514547, 514548, A61K 3144
Patent
active
051662124
ABSTRACT:
Disclosed are compound of the formula ##STR1## wherein X and Y independently represent hydroxymethyl; cyano; carboxy; functionally modified carboxy selected from esterified carboxy, carbamoyl, and N-substituted carbamoyl; 5-tetrazolyl; 2-oxazolyl, 4,5-dihydro-2-oxazolyl, or each said grouping substituted by lower alkyl; R and R.sub.o independently represent lower alkyl, (C.sub.3 -C.sub.7)-cycloalkyl-lower alkyl, or aryl-lower alkyl; A represents methylene; or A represents methylene substituted by lower alkyl, by lower alkylthio-lower alkyl, by aryl-lower alkylthio-lower alkyl, by arylthio-lower alkyl, by hydroxy-lower alkyl, by acyloxy-lower alkyl, by lower alkoxy-lower alkyl, by alkyloxy-lower alkyl, by aryloxy-lower alkyl, by amino-lower alkyl by acylamino-lower alkyl, by guanidino-lower amino-lower alkyl, by (C.sub.3 -C.sub.7)-cycloalkyl, by (C.sub.3 -C.sub.7)-cycloalkyl-lower alkyl, by aryl or aryl-lower alkyl; pharmaceutically acceptable ester and amide derivatives of any said compounds having a free carboxy group; pharmaceutically acceptable salts; methods for synthesis; pharmaceutical compositions thereof; and use thereof as endopentidase inhibitors.
REFERENCES:
patent: 4052511 (1977-10-01), Cushman et al.
patent: 4116962 (1978-09-01), Ondetti et al.
patent: 4228184 (1980-10-01), Ondetti et al.
patent: 4311705 (1982-01-01), Ondetti et al.
patent: 4374847 (1983-02-01), Gruenfeld
patent: 4504492 (1985-03-01), Wilkinson et al.
patent: 4610816 (1986-09-01), Berger
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4939261 (1990-07-01), Ksanler
Hoffman et al., Chem. Ber., 115, 2357 (1982).
Hershenson et al., J. Org. Chem., 40, 1260 (1975).
Oppenheimer et al., J. Biol. Chem., 254, 5184-5190 (1979).
Cushman et al., Biochemistry, 16, 5484 (1977).
J. Med. Chem, 26, 1277-1282 (1983).
Llorens et al., Biochem. Biophys. Res. Comm., 96, 1710-16.
Mumford et al., Biochem. Biophys. Res. Comm., 109, 1303-09 (1982).
Roques et al., Life Sciences, 31, 1749-52 (1982).
Fournie-Zaluski, et al., Life Sciences 31, 2947-54 (1982).
Derwent Abstract 86-020885/03 of European patent application No. 185,079.
WO 86/00066 (1986).
Ciba-Geigy Corporation
Dees Jos,e G.
Frazier B.
Gruenfeld Norbert
LandOfFree
Certain n-substituted butyramide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Certain n-substituted butyramide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Certain n-substituted butyramide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-922135